COMMENT Russia’s focus on domestic pharma production could shield it from sanctions Heart failure: charting the clinical trial landscape in the past decade Delayed EMA approval: improved safety or lack of access to therapeutics? Non-stop investment from CMOs and US Government into continuous manufacturing Drug Development A disappointing June for Alzheimer’s disease signals setbacks for several products Several companies have announced poor results from clinical trials for Alzheimer’s disease therapies this month. insight Europe reports the highest prevalence of chronic cough comment Could vaccine hesitancy impact hearing disorders? Russia’s focus on domestic pharma production could shield it from sanctions Heart failure: charting the clinical trial landscape in the past decade Delayed EMA approval: improved safety or lack of access to therapeutics? Non-stop investment from CMOs and US Government into continuous manufacturing 07/22/2022 09:35:43
Russia’s focus on domestic pharma production could shield it from sanctions
Heart failure: charting the clinical trial landscape in the past decade
Delayed EMA approval: improved safety or lack of access to therapeutics?
Non-stop investment from CMOs and US Government into continuous manufacturing